Marc Mahl brings a comprehensive portfolio to the Management Board with extensive experience in the pharmaceutical and nutrition industry. His focus is on strategy, development, production, M&A, and reorganization management. Before his current position, he served as Head of Business Unit Generics and IV Fluids EU & RoW of Fresenius Kabi.

2020年9月1日 · 现年52岁的Marc Alexander Mahl博士将于2021年1月1日起担任首席运营官一职。Mahl紧随2019年底离开公司的斯特凡·埃克特（Stefan Eckert）。首席执行官因戈·穆勒（Ingo muller）暂时负责该部门。Mahl来自Fresenius Kabi，一家活跃于临床营养、输液治疗、仿制药和医药产品的公司。

2020年9月4日 · Dr Marc-Alexander Mahl (52) will take on the position of Chief Operating Officer (COO) from 1 January 2021. The new manager is from Fresenius Kabi. Mahl follows Stefan Eckert who left the company at the end of 2019. CEO Ingo Müller has been responsible for the unit on an interim basis.

Dr. Marc-Alexander Mahl holds an eMBA from INSEAD, a MD degree from University Essen, a medical doctorate from University Bochum and a specialization degree in Transfusion medicine. Mahl has been associated with the Fresenius group since 2001.

Marc-Alexander Mahl President Medicines for Europe and Executive Vice President, Business Unit Generics and Complex Formulations ELAMA & Asia-Pacific Pharmaceuticals and Devices …

Marc Mahl, director with Fresenius Kabi Oncology Limited, is registered with the Ministry of Corporate Affairs (MCA), bearing DIN 10279843. Marc Mahl is currently associated with Fresenius Kabi Oncology Limited appointed as Additional Director and the paid-up capital Fresenius Kab See More...

Dr. Marc-Alexander Mahl übernimmt kommendes Jahr die Position des Chief Operating Officers (COO) im Management des Geschäftsfeldes Babynahrung bei der DMK Group, Bremen. Der Manager kommt von Fresenius Kabi, einem Anbieter in den Segmenten klinische Ernährung, Infusionstherapie, generische Arzneimittel und Medizinprodukte.

Dr. Marc-Alexander Mahl (52) will be the new COO of the Baby Food business unit in the DMK Group. He follows Stefan Eckert who left the company at the end of 2019. CEO Ingo Müller has been responsible for the unit on an interim basis.